European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Human refused centr
- Sumatriptan Galpharm
Community Register of medicinal products
List of refusals for human medicinal products
Sumatriptan Galpharm
| Product name: | Sumatriptan Galpharm |
| INN: | sumatriptan |
| Indication: | Acute relief of migraine attacks, with or without aura. Sumatriptan Galpharm should only be used where there is a clear diagnosis of migraine |
| Marketing Authorisation Holder: | Galpharm Healthcare Ltd. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 13/02/2012 | Centralised - Refusal of marketing authorisation | EMEA/H/C/2140 | (2012)895 of 09/02/2012 |